Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial - Muller, Roberto L.; Gerber, Leah; Moreira, Daniel M.; Andriole, Gerald; Castro-Santamaria, Ramiro; Freedland, Stephen J. (European urology, 2012)
Keywords: 5-alpha Reductase Inhibitors - therapeutic use; 5α-Reductase inhibitors/therapeutic use; Aged; Antineoplastic Agents, Hormonal - therapeutic use; Azasteroids - therapeutic use; Biological and medical sciences; Biopsy; Dihydrotestosterone - blood; Double-Blind Method; Dutasteride; Gonadal steroid hormones; Gynecology. Andrology. Obstetrics; Humans; Kallikreins - blood; Logistic Models; Male; Male genital diseases; Medical sciences; Middle Aged; Multivariate Analysis; Neoplasm Grading; Neoplasms, Hormone-Dependent - blood; Neoplasms, Hormone-Dependent - drug therapy; Neoplasms, Hormone-Dependent - epidemiology; Neoplasms, Hormone-Dependent - pathology; Nephrology. Urinary tract diseases; Odds Ratio; Placebos; Prospective Studies; Prostate-Specific Antigen - blood; Prostatic Neoplasms - blood; Prostatic Neoplasms - drug therapy; Prostatic Neoplasms - epidemiology; Prostatic Neoplasms - pathology; Prostatic neoplasms/diagnosis; Research Design; Testosterone - blood; Time Factors; Treatment Outcome; Tumors; Tumors of the urinary system; Up-Regulation; Urinary tract. Prostate gland; Urology; 5α-Reductase inhibitors/therapeutic use; Prostate-specific antigen/blood; Middle-aged; Prostatic neoplasms/diagnosis; Gonadal steroid hormones; Prostate tumor; Nephrology; Prostate disease; Tumoral marker; Antihormone; Blood; Urology; Prostate specific antigen; Dihydrotestosterone; Reduction; Clinical trial; Serum; Testicular hormone; Diagnosis; 5α-Reductase inhibitors/ therapeutic use; Male genital diseases; 3-Oxo-5α-steroid 4-dehydrogenase; Urinary system disease; Middle age; Androgen; Enzyme; Steroid hormone; Enzyme inhibitor; Antiandrogen; Malignant tumor; Azasteroid; Testosterone; Treatment; Risk factor; Placebo; Dutasteride; Oxidoreductases; Sex steroid hormone; Arm; Prostate cancer; Cancer